Back to feed
GANXGain Therapeutics, Inc.
CIK 0001819411 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Institution-led2/5 sources
18/100
Recent disclosures · timeline
- 8-K5.073d ago
Submission of matters to a shareholder vote
Price · GANX
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Material events · 8-K
GANX corporate events · live SEC data- 5.073d ago
Submission of matters to a shareholder vote
Form 8-K — items reported: 5.07 Submission of matters to a shareholder vote.
Item 5.07 · Submission of matters to a shareholder voteView 8-K on EDGAR ↗
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data5 funds hold$3.72M reported valueNet reducing(3 adding · 3 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| Vanguard Group Inc | 569,901 | $1.84M | 0.0% | Add+7% |
| Greenlight Capital Inc David Einhorn | 566,130 | $1.10M | 0.3% | Hold |
| BlackRock Inc | 225,046 | $436.6K | 0.0% |
Recent insider transactions
No insider transactions recorded for GANX.